SEC Filing Summary: AntriaBio, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AntriaBio, Inc. on June 22, 2016. The filing serves as a Regulation FD disclosure, furnishing a press release (Exhibit 99.1) issued on the same date. The registrant is incorporated in Delaware with principal executive offices in Louisville, CO. Note: The request metadata referenced "Rezolute, Inc.," but the filing text explicitly identifies the registrant as AntriaBio, Inc.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose a press release and does not contain audited financial statements or detailed financial data within the body of the report.
Material Changes
No material financial changes or operational updates are detailed in the text of this Form 8-K. The filing solely references the issuance of a press release attached as Exhibit 99.1, the content of which is not included in the provided text.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, or specific risk factors. It explicitly states that the information is "furnished" and not "filed" for purposes of the Securities Exchange Act of 1934, and it shall not be deemed an admission as to the materiality of any information required solely to satisfy Regulation FD.
Key Facts for Investor Verification
- Registrant Identity: Verify that the filing pertains to AntriaBio, Inc., not Rezolute, Inc.
- Press Release Content: The substantive information is located in Exhibit 99.1 (Press Release dated June 22, 2016), which is referenced but not included in the provided text.
- Filing Status: The information is furnished under Regulation FD and is not considered "filed" for liability purposes under the Exchange Act.
- Financial Data: No financial metrics are present in this specific document; investors must refer to the attached press release or other periodic reports (10-K/10-Q) for financial data.